A catalytically inactive beta 1,4-N-acetylglucosaminyltransferase III (GnT-III) behaves as a dominant negative GnT-III inhibitor.

beta 1,4-N-Acetylglucosaminyltransferase III (GnT-III) plays a regulatory role in the biosynthesis of N-glycans, and it has been suggested that its product, a bisecting GlcNAc, is involved in a variety of biological events as well as in regulating the biosynthesis of the oligosaccharides. In this study, it was found, on the basis of sequence homology, that GnT-III contains a small region that is significantly homologous to both snail beta 1,4GlcNAc transferase and beta1,4Gal transferase-1. Subsequent mutational analysis demonstrated an absolute requirement for two conserved Asp residues (Asp321 and Asp323), which are located in the most homologous region of rat GnT-III, for enzymatic activity. The overexpression of Asp323-substituted, catalytically inactive GnT-III in Huh6 cells led to the suppression of the activity of endogenous GnT-III, but no significant decrease in its expression, and led to a specific inhibition of the formation of bisected sugar chains, as shown by structural analysis of the total N-glycans from the cells. These findings indicate that the mutant serves a dominant negative effect on a specific step in N-glycan biosynthesis. This type of 'dominant negative glycosyltransferase', identified has potential value as a powerful tool for defining the precise biological roles of the bisecting GlcNAc structure.

[1]  G. Davies,et al.  Structure of the nucleotide-diphospho-sugar transferase, SpsA from Bacillus subtilis, in native and nucleotide-complexed forms. , 1999, Biochemistry.

[2]  P Berg,et al.  Electroporation for the efficient transfection of mammalian cells with DNA. , 1987, Nucleic acids research.

[3]  K. Yamamura,et al.  Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Kunkel.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[5]  L. Juneja,et al.  Occurence of a sialylglycopeptide and free sialylglycans in hen's egg yolk. , 1997, Biochimica et biophysica acta.

[6]  S. Munro,et al.  A Common Motif of Eukaryotic Glycosyltransferases Is Essential for the Enzyme Activity of Large Clostridial Cytotoxins* , 1998, The Journal of Biological Chemistry.

[7]  S. Narasimhan.  Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. , 1982, The Journal of biological chemistry.

[8]  Y. Matsuzawa,et al.  Aberrant Glycosylation of E-cadherin Enhances Cell-Cell Binding to Suppress Metastasis* , 1996, The Journal of Biological Chemistry.

[9]  L. Tabak,et al.  Structure-function analysis of the UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. Essential residues lie in a predicted active site cleft resembling a lactose repressor fold. , 1999, The Journal of biological chemistry.

[10]  Y. Ikeda,et al.  Human γ-Glutamyl Transpeptidase Mutants Involving Conserved Aspartate Residues and the Unique Cysteine Residue of the Light Subunit (*) , 1995, The Journal of Biological Chemistry.

[11]  R. Cummings,et al.  Expression Cloning of a New Member of the ABO Blood Group Glycosyltransferases, iGb3 Synthase, That Directs the Synthesis of Isoglobo-glycosphingolipids* , 2000, The Journal of Biological Chemistry.

[12]  S. Fujii,et al.  Glycosyltransferase assays using pyridylaminated acceptors: N-acetylglucosaminyltransferase III, IV, and V. , 1989, Methods in enzymology.

[13]  Y. Arakawa,et al.  Conserved Structural Regions Involved in the Catalytic Mechanism of Escherichia coli K-12 WaaO (RfaI) , 1998, Journal of bacteriology.

[14]  N. Taniguchi,et al.  Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Cummings,et al.  Cloning of Gb3 Synthase, the Key Enzyme in Globo-series Glycosphingolipid Synthesis, Predicts a Family of α1,4-Glycosyltransferases Conserved in Plants, Insects, and Mammals* , 2000, The Journal of Biological Chemistry.

[16]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[17]  Stephen G. Withers,et al.  Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs , 2001, Nature Structural Biology.

[18]  S. Evans,et al.  Dominant negative mutation in cell surface beta 1,4- galactosyltransferase inhibits cell-cell and cell-matrix interactions , 1993, The Journal of cell biology.

[19]  S. Munro,et al.  Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Fujii,et al.  Carbohydrate analysis of immunoglobulin G myeloma proteins by lectin and high performance liquid chromatography: role of glycosyltransferases in the structures. , 1990, Cancer research.

[21]  C. Koeleman,et al.  A Lymnaea stagnalis gene, with sequence similarity to that of mammalian beta 1-->4-galactosyltransferases, encodes a novel UDP-GlcNAc:GlcNAc beta-R beta 1-->4-N-acetylglucosaminyltransferase. , 1994, The Journal of biological chemistry.

[22]  N. Taniguchi,et al.  Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: beta-D-mannoside beta-1,4N-acetylglucosaminyltransferase III from rat kidney. , 1992, The Journal of biological chemistry.

[23]  R. Watanabe,et al.  PIG‐M transfers the first mannose to glycosylphosphatidylinositol on the lumenal side of the ER , 2001, The EMBO journal.

[24]  T. Hada,et al.  Enzymatic basis of sugar structures of α‐fetoprotein in hepatoma and hepatoblastoma cell lines: Correlation with activities of α1–6 fucosyltransferase and N‐acetylglucosaminyltransferases III and V , 1992, International journal of cancer.

[25]  S Hase,et al.  Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. , 1984, Journal of biochemistry.

[26]  S. Fujii,et al.  A method for the determination of N-acetylglucosaminyltransferase III activity in rat tissues involving HPLC. , 1988, Analytical biochemistry.

[27]  P. Gleeson,et al.  Control of branching during the biosynthesis of asparagine-linked oligosaccharides. , 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

[28]  K. Mikoshiba,et al.  Pyridylamino sugar chain as an acceptor for galactosyltransferase. , 1988, Journal of biochemistry.

[29]  C. Rogler,et al.  New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice. , 2000, Cancer research.

[30]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[31]  C. Rogler,et al.  Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression. , 1998, Cancer research.

[32]  Christian Cambillau,et al.  Crystal structures of the bovine β4galactosyltransferase catalytic domain and its complex with uridine diphosphogalactose , 1999, The EMBO journal.

[33]  A. Sultan,et al.  Bisecting GlcNAc Structures Act as Negative Sorting Signals for Cell Surface Glycoproteins in Forskolin-treated Rat Hepatoma Cells* , 1997, The Journal of Biological Chemistry.

[34]  A. Imberty,et al.  Sequence-function relationships of prokaryotic and eukaryotic galactosyltransferases. , 1998, Journal of biochemistry.

[35]  J. Rini,et al.  X‐ray crystal structure of rabbit N‐acetylglucosaminyltransferase I: catalytic mechanism and a new protein superfamily , 2000, The EMBO journal.

[36]  S. Munro,et al.  The Notch signalling regulator Fringe acts in the Golgi apparatus and requires the glycosyltransferase signature motif DxD , 2000, Current Biology.

[37]  Y. Matsuzawa,et al.  Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing β1,4‐N‐acetylglucosaminyltransferase III , 1997, International journal of cancer.

[38]  T. Darden,et al.  Heparan/Chondroitin Sulfate Biosynthesis , 2000, The Journal of Biological Chemistry.

[39]  R. Parekh,et al.  Use of hydrazine to release in intact and unreduced form both N- and O-linked oligosaccharides from glycoproteins. , 1993, Biochemistry.

[40]  N. Taniguchi,et al.  N-glycosylation is requisite for the enzyme activity and Golgi retention of N-acetylglucosaminyltransferase III. , 1997, Glycobiology.

[41]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[42]  H. Schachter,et al.  Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. , 1986, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[43]  Y. Ikeda,et al.  Kinetic Basis for the Donor Nudeotide-Sugar Specificity of βl,4-N-Acetylglucosaminyltransferase III , 2000 .

[44]  O Hindsgaul,et al.  Bovine α1,3‐galactosyltransferase catalytic domain structure and its relationship with ABO histo‐blood group and glycosphingolipid glycosyltransferases , 2001, The EMBO journal.

[45]  A. Menon,et al.  The DXD motif is required for GM2 synthase activity but is not critical for nucleotide binding. , 2001, Glycobiology.